Back to search

France· FR:61238347

INEGY 10 mg/40 mg, comprimé

A medicinal product containing simvastatine + ézétimibe, registered in France by BB FARMA (ITALIE), on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedINEGY 10 mg/40 mg, compriméATC—REGISTER NO.FR:61238347PACKS LISTED2CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
SIMVASTATINE + ÉZÉTIMIBE
Manufacturer
BB FARMA (ITALIE)
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400949003181
    plaquette(s) polychlortrifluoroéthylène PVC-Aluminium de 30 comprimé(s)
    EUR 14.49
  • cip13
    3400949003198
    plaquette(s) polychlortrifluoroéthylène PVC-Aluminium de 90 comprimé(s)
    EUR 41.01

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Simvastatine + ézétimibe in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All simvastatine + ézétimibe products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Ezesim, Ezetimib/Simvastatin Accord
  • Belgium · Ezetimib/Simvastatin Ab, Ezetimibe/Simvastatin Krka
  • Cyprus · Ezetimibe/Simvastatin Accord, Inegy
  • Czechia · Ezetimibe/Simvastatin Teva Cr, Glezisim
  • Germany · Ezesimin, Ezetimib Simvastatin Zentiva
  • Denmark · Ezetimib/Simvastatin Demo, Ezetimib/Simvastatin Hexal
  • Spain · Ezetimiba/Simvastatina Alter, Ezetimiba/Simvastatina Aurovitas
  • United Kingdom (Northern Ireland) · Ezetimibe/Simvastatin Accord Healthcare, Ezetimibe/Simvastatin Ascend Laboratories
  • Greece · Cildar Plus, Ezetimib/Simvastatin Mylan
  • Croatia · Inegy, Vasitimb
  • Hungary · Inegy
  • Ireland · Ezetimibe/Simvastatin Clonmel, Ezetimibe/Simvastatin Krka
  • Iceland · Ezetimib/Simvastatin Krka, Inegy
  • Italy · Ezetimibe E Simvastatina Accord, Ezetimibe E Simvastatina Almus
  • Luxembourg · Ezetimib/Simvastatin Ratiopharm®, Ezetimibe/Simvastatine Eg
  • Netherlands · Ezetimibe/Simvastatin Aurobindo, Ezetimibe/Simvastatine Cf
  • Norway · Ezetimib/Simvastatin Glenmark, Ezetimib/Simvastatin Krka
  • Portugal · Inegy, Sinvastatina + Ezetimiba Alter
  • Sweden · Ezetimib/Simvastatin Krka, Ezetimibe/Simvastatin Accord
  • Slovenia · Inegy, Vasitimb
  • Slovakia · Cornusan, Ezetimib/Simvastatín Teva B.V.

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c67c9325-825e-4bab-ba82-f53bb601fa03
GET /v1/drugs/c67c9325-825e-4bab-ba82-f53bb601fa03?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61238347",
  "date_amm": "2019-04-30",
  "type_amm": "Autorisation d'importation parallèle",
  "numero_ue": null,
  "substance": "SIMVASTATINE + ÉZÉTIMIBE",
  "statut_amm": "Autorisation abrogée",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "comprimé",
  "voies_administration": "orale",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about simvastatine + ézétimibe.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.